Source comparison
TB-500 Sports Injury Mechanism: Protocol Comparison
Acute muscle strain (Grade I–II) 2–2.5mg twice weekly for 4 weeks, then maintenance 2mg weekly for 2–4 weeks Actin-mediated cell migration + angiogenesis Functional recovery 30–40% faster than control; return to activity 3–4 weeks vs 5–6 weeks Acute strains re
This comparison does not assign a generated winner or score.
- Acute muscle strain (Grade I–II)
- 2–2.5mg twice weekly for 4 weeks, then maintenance 2mg weekly for 2–4 weeks
- Actin-mediated cell migration + angiogenesis
- Functional recovery 30–40% faster than control; return to activity 3–4 weeks vs 5–6 weeks
- Acute strains respond best to early intervention. Administer within 48 hours of injury for maximum migration and VEGF response
- Chronic tendinopathy (Achilles, patellar)
- 2.5mg twice weekly for 6–8 weeks
- MMP upregulation + collagen remodeling + NF-κB suppression
- Symptom reduction noticeable at 3–4 weeks; structural improvement on ultrasound by 8–10 weeks
- Chronic conditions require longer protocols. TB-500's collagen remodeling effect scales with exposure duration, not peak dose
- Ligament sprain (Grade II)
- 2–3mg twice weekly for 6 weeks, reduce to 2mg weekly maintenance
- VEGF-driven revascularization + fibroblast migration
- Stability improvement by week 4–5; full load tolerance 8–10 weeks
- Ligament healing is vascularization-limited. TB-500's angiogenic effect addresses the bottleneck that delays recovery in avascular structures
- Post-surgical recovery (ACL reconstruction, rotator cuff repair)
- 2.5mg twice weekly starting 7 days post-op, continue 8–12 weeks
- Scar tissue modulation + accelerated collagen deposition + reduced adhesion formation
- Reduced stiffness/ROM restrictions by week 6; return to sport 15–20% faster than rehab-only protocols
- Surgical trauma creates large-scale tissue disruption. TB-500's migration and MMP effects prevent excessive scar formation while supporting functional tissue repair